Bipartisan Commission on Biodefense

Biodefense study

Based in DC

🤖

AI Overview

With $530K in lobbying spend across 27 quarterly filings, Bipartisan Commission on Biodefense is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2024.

$530K
Total Spend
7
Years Active
1
Firms Hired
7
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$80K
2019$80K
2020$80K
2021$80K
2022$80K
2023$80K
2024$50K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Bipartisan Commission on Biodefense disclosed contacting in their lobbying filings.

Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)Homeland Security, Dept of (DHS)HOUSE OF REPRESENTATIVESSENATEOffice of Management & Budget (OMB)Centers For Disease Control & Prevention (CDC)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Homeland Security, Health Issues, Budget/Appropriations

Discussions regarding health, agriculture, and security issues

Science and technology discussions as well as general discussions regarding defense

H.R. 2367/S. 1662, FY 2018 Commerce, Justice, Science

Discussions regarding health, agriculture, and security issues

Science and technology discussions as well as general discussions regarding defense

H.R.5515, FY 2019 National Defense Authorization Act

Discussions regarding health, homeland security, and appropriations

S.3107, H.R.6258 - FY2019 Financial Services Appropriations Act

S.2852, H.R.6378 - Pandemic and All-Hazards Preparedness and Advanci

Discussions regarding H.R.269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.